背景:体外膜氧合(ECMO)是一种重症监护干预措施,可作为心脏和肺的临时替代品,促进充分的组织灌注和气体交换。2个主要配置,静脉动脉和静脉-静脉ECMO,是专为支持心脏和肺或仅支持肺而设计的,分别。
方法:病例报告详述了肿瘤引起的气道狭窄患者在标准治疗中遇到的限制,不足或有严重并发症如缺氧和窒息的风险。
方法:患者被诊断为由甲状腺肿引起的严重气道狭窄,在管理过程中需要创新的治疗方法来防止并发症。
方法:采用静脉-静脉ECMO作为桥接疗法,在肿瘤切除过程中提供重要的呼吸支持。这种干预对于降低与气道水肿或肿瘤破裂相关的风险至关重要。
结果:使用静脉-静脉ECMO,患者成功进行了肿瘤切除。他们随后脱离了ECMO的支持,经过一个疗程,他们状况良好,已出院。
结论:该病例证明了静脉-静脉ECMO作为治疗甲状腺肿引起的严重气道狭窄的桥接治疗的有效性。它的使用促进了肿瘤的成功切除,并导致了积极的患者结果,强调其在类似情况下作为有价值的治疗选择的潜力。
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a critical care intervention that acts as a temporary substitute for the heart and lungs, facilitating adequate tissue perfusion and gas exchange. The 2 primary configurations, veno-arterial and veno-venous ECMO, are tailored to support either the heart and lungs or the lungs alone, respectively.
METHODS: The case report details patients with tumor-induced airway stenosis who encountered limitations with standard treatments, which were either insufficient or carried the risk of severe complications such as hypoxia and asphyxia.
METHODS: Patients were diagnosed with severe airway stenosis caused by
goiter, a condition that required innovative treatment approaches to prevent complications during the management process.
METHODS: Veno-venous ECMO was implemented as a bridging therapy to provide vital respiratory support during the tumor resection procedure. This intervention was crucial in reducing the risks associated with airway edema or tumor rupture.
RESULTS: With the use of veno-venous ECMO, the patients successfully underwent tumor resection. They were subsequently weaned off the ECMO support, and after a course of treatment, they were discharged in good condition.
CONCLUSIONS: The case demonstrates the efficacy of veno-venous ECMO as a bridging therapy for managing severe airway stenosis caused by
goiter. Its use facilitated the successful resection of tumors and led to positive patient outcomes, highlighting its potential as a valuable treatment option in similar scenarios.